Toronto, Ontario – TheNewswire - November 6, 2025 – Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Corporation"), (TSXV:VPT) is pleased to announce that it has agreed to settle an aggregate of $542,591.50 of debt owed to certain arm’s length creditors of the Corporation by issuing an aggregate of 5,425,915 common shares (the “Shares”) of the Corporation at a price of $0.10 per share.  The Shares are subject to a hold period of four-month and one day. The Corporation determined to satisfy the indebted ...